Literature DB >> 8070919

Management of the short bowel syndrome.

J S Thompson1.   

Abstract

The short bowel syndrome has become an increasingly common clinical condition. Malnutrition and its complications should be avoidable with use of a combination of enteral and parenteral nutrition support. Dietary management needs to be individualized. Drugs directed against gastric hypersecretion, increased motility, intestinal secretion, unabsorbed bile salts, and bacterial overgrowth improve intestinal function. Complications specific to the short bowel syndrome (gastric hypersecretion, cholelithiasis, nephrolithiasis) can be minimized and diagnosed early. Surgical management includes preserving intestinal remnant length and improving its function. Intestinal transplantation is evolving as a promising therapeutic alternative for patients with complications of long-term parenteral nutrition support.

Entities:  

Mesh:

Year:  1994        PMID: 8070919

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  8 in total

1.  Open abdomen management after massive bowel resection for superior mesenteric arterial occlusion.

Authors:  Kenji Mimatsu; Takatsugu Oida; Hisao Kanou; Hiroshi Miyake; Sadao Amano
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Hyaluronic acid based materials for intestine tissue engineering: a morphological and biochemical study of cell-material interaction.

Authors:  A Esposito; A Mezzogiorno; A Sannino; A De Rosa; D Menditti; V Esposito; L Ambrosio
Journal:  J Mater Sci Mater Med       Date:  2006-12       Impact factor: 3.896

Review 3.  The surgical management of short bowel syndrome.

Authors:  Edward M Barksdale; Ala Stanford
Journal:  Curr Gastroenterol Rep       Date:  2002-06

4.  Tissue-engineered small intestine improves recovery after massive small bowel resection.

Authors:  Tracy C Grikscheit; Aleem Siddique; Erin R Ochoa; Ashok Srinivasan; Eben Alsberg; Richard A Hodin; Joseph P Vacanti
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

5.  A multicellular approach forms a significant amount of tissue-engineered small intestine in the mouse.

Authors:  Frédéric G Sala; Jamil A Matthews; Allison L Speer; Yasuhiro Torashima; Erik R Barthel; Tracy C Grikscheit
Journal:  Tissue Eng Part A       Date:  2011-05-04       Impact factor: 3.845

Review 6.  Surgical therapy for short bowel syndrome.

Authors:  Paul W Wales
Journal:  Pediatr Surg Int       Date:  2004-09-24       Impact factor: 1.827

7.  Intestinal stem cell organoid transplantation generates neomucosa in dogs.

Authors:  Vatche G Agopian; David C Chen; Jeffrey R Avansino; Matthias Stelzner
Journal:  J Gastrointest Surg       Date:  2009-01-23       Impact factor: 3.452

8.  Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome.

Authors:  Kristina S Chen; Jipan Xie; Wenxi Tang; Jing Zhao; Palle B Jeppesen; James E Signorovitch
Journal:  Ther Clin Risk Manag       Date:  2018-07-25       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.